{"filing":{"accession_number":"0001213900-26-085920","cik":"0001795251","ticker":"NNOX","company_name":"Nano-X Imaging Ltd.","form":"6-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"ea0300882-6k_nanox.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1795251/000121390026085920/ea0300882-6k_nanox.htm"},"events":[{"id":24512,"run_id":22217,"accession_number":"0001213900-26-085920","anchor_item_number":"EX-99.1","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This press release announces a registered direct offering of 8 million ordinary shares and 8 million warrants at $1.00 per unit, raising approximately $8 million gross proceeds. The offering is a registered direct placement under the company's Form F-3 shelf registration, representing a dilutive equity issuance to a single institutional investor. The warrant component (exercisable at $1.15, expiring five years from closing) adds further dilution potential. This is a material capital-raising event for a medical imaging company with acknowledged going-concern risks mentioned in the forward-looking statements.","company_name":"Nano-X Imaging Ltd.","ticker":"NNOX","filing_date":"2026-08-06","form":"6-K","submitted_at":null,"items":[{"id":25102,"accession_number":"0001213900-26-085920","item_number":"EX-99.1","item_title":"ea030088201ex99-1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This press release announces a registered direct offering of 8 million ordinary shares and 8 million warrants at $1.00 per unit, raising approximately $8 million gross proceeds. The offering is a registered direct placement under the company's Form F-3 shelf registration, representing a dilutive equity issuance to a single institutional investor. The warrant component (exercisable at $1.15, expiring five years from closing) adds further dilution potential. This is a material capital-raising event for a medical imaging company with acknowledged going-concern risks mentioned in the forward-looking statements.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:01:47.912246+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25102,"accession_number":"0001213900-26-085920","item_number":"EX-99.1","item_title":"ea030088201ex99-1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This press release announces a registered direct offering of 8 million ordinary shares and 8 million warrants at $1.00 per unit, raising approximately $8 million gross proceeds. The offering is a registered direct placement under the company's Form F-3 shelf registration, representing a dilutive equity issuance to a single institutional investor. The warrant component (exercisable at $1.15, expiring five years from closing) adds further dilution potential. This is a material capital-raising event for a medical imaging company with acknowledged going-concern risks mentioned in the forward-looking statements.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:01:47.912246+00:00","company_name":"Nano-X Imaging Ltd.","ticker":"NNOX","filing_date":"2026-08-06"}]}